QURE
uniQureยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
QURE Profile
Uniqure N.V.
A leading gene therapy company that develops innovative treatments for genetic diseases
Paasheuvelweg 25a, 1105 BP Amsterdam, The Netherlands
--
UniQure N.V. was established as a private limited liability company on January 9, 2012 in accordance with the relevant provisions of the Dutch law. The company is a biotechnology company specializing in gene therapy, dedicated to the development of a single treatment pathway for rare and critically ill patients. Its pipeline includes clinical drug candidates for Huntington's disease, amyotrophic lateral sclerosis associated with SOD 1 mutations, refractory median temporal lobe epilepsy and Fabry disease, reflecting the focus on advancing innovative therapies in the field of gene therapy.
